Literature DB >> 9459503

Comprehensive HLA-DP typing using polymerase chain reaction with sequence-specific primers and 95 sequence-specific primer mixes.

F C Gilchrist1, M Bunce, P A Lympany, K I Welsh, R M du Bois.   

Abstract

HLA-DP is the third of the class II molecules. Its role is antigen presentation, and it has been suggested to play a part in the susceptibility to certain diseases such as berylliosis, sarcoidosis and juvenile chronic arthritis. The standard typing method is SSO typing, although other methods have been used. Probably the best is sequence-based typing, but this is time-consuming and requires expensive equipment. We describe a method for comprehensive HLA-DPB1 and HLA-DPA1 typing using sequence-specific primers. This method has the advantages that it is rapid - typing a single DNA sample takes under 3 hours - and does not require any special equipment or reagents. The method has been shown to be highly accurate by typing 60 cell line DNA samples in which there was 100% agreement between the types obtained and the published information. Similarly typing of 20 DNA samples previously typed by sequence-based typing gave 100% concordance. We used the method to type DNA samples from 102 UK Caucasoid kidney donors. The allele frequencies agree with previously published data. Linkage disequilibria between HLA-DPB1, HLA-DPA1 and the other class II antigens have been investigated. Strong linkage disequilibria exist between certain HLA-DPB1 and HLA-DPA1 alleles. This is unsurprising in view of their proximity on the chromosome. More unexpectedly, the data also suggest that genes further away along the chromosome are in linkage disequilibrium with HLA-DP, forming extended haplotypes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9459503     DOI: 10.1111/j.1399-0039.1998.tb02946.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  7 in total

1.  Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease.

Authors:  A P Fontenot; M Torres; W H Marshall; L S Newman; B L Kotzin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

2.  p38 Mitogen-Activated Protein Kinase in beryllium-induced dendritic cell activation.

Authors:  L Li; Z Huang; M Gillespie; P M Mroz; L A Maier
Journal:  Hum Immunol       Date:  2014-10-22       Impact factor: 2.850

Review 3.  Beryllium-Induced Hypersensitivity: Genetic Susceptibility and Neoantigen Generation.

Authors:  Andrew P Fontenot; Michael T Falta; John W Kappler; Shaodong Dai; Amy S McKee
Journal:  J Immunol       Date:  2016-01-01       Impact factor: 5.422

4.  Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers.

Authors:  Mike V Van Dyke; John W Martyny; Margaret M Mroz; Lori J Silveira; Matt Strand; Tasha E Fingerlin; Hiroe Sato; Lee S Newman; Lisa A Maier
Journal:  Am J Respir Crit Care Med       Date:  2011-03-11       Impact factor: 21.405

5.  HLA-DPB1 E69 genotype and exposure in beryllium sensitisation and disease.

Authors:  James Crooks; Margaret M Mroz; Michael VanDyke; Alison McGrath; Christine Schuler; Erin C McCanlies; M Abbas Virji; Kenneth D Rosenman; Milton Rossman; Carol Rice; Dimitri Monos; Tasha E Fingerlin; Lisa A Maier
Journal:  Occup Environ Med       Date:  2021-09-17       Impact factor: 4.402

Review 6.  Genetic studies of IgA nephropathy: what have we learned from genome-wide association studies.

Authors:  Jingyuan Xie; Samantha Shapiro; Ali Gharavi
Journal:  Contrib Nephrol       Date:  2013-05-08       Impact factor: 1.580

Review 7.  T cell recognition of beryllium.

Authors:  Shaodong Dai; Michael T Falta; Natalie A Bowerman; Amy S McKee; Andrew P Fontenot
Journal:  Curr Opin Immunol       Date:  2013-08-23       Impact factor: 7.486

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.